stockportfolio.pro
TransMedics Group, Inc. Free Cash Flow 2018–2025
TransMedics Group, Inc. (TMDX) annual free cash flow by fiscal year, computed from SEC filings.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $133.59M | +265.0% |
| FY 2024 | $-80.94M | +50.9% |
| FY 2023 | $-164.88M | -185.6% |
| FY 2022 | $-57.72M | -78.3% |
| FY 2021 | $-32.38M | -5.4% |
| FY 2020 | $-30.72M | +5.3% |
| FY 2019 | $-32.45M | -22.9% |
| FY 2018 | $-26.40M | — |
Source: TransMedics Group, Inc. SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for TransMedics Group, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTransMedics Group, Inc. — frequently asked questions
What is TransMedics Group, Inc.'s free cash flow?
TransMedics Group, Inc. (TMDX) reported free cash flow of $133.59M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from TransMedics Group, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.